Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
CyberKnife Cost-Effective in the Long-Term
By
Debra Wood, RN
Genitourinary Cancers Symposium
,
Prostate Cancer
April 2011, Vol 2, No 2
Read More
Mutational Analysis Leads Search for New Treatments for Bladder Cancer
By
Debra Wood, RN
Bladder Cancer
,
Genitourinary Cancers Symposium
April 2011, Vol 2, No 2
Read More
Abiraterone Acetate Prolongs Survival in Metastatic Prostate Cancer
By
Debra Wood, RN
Genitourinary Cancers Symposium
April 2011, Vol 2, No 2
Read More
Accelerating Growth in REMS Programs a Challenge for Oncologists
By
Daniel Denvir
ACCC Conference
April 2011, Vol 2, No 2
Addressing the 2011 Association of Community Cancer Centers annual meeting attendees,
Timothy Tyler, PharmD, FCSHP
, Director of Pharmacy Services at the Desert Regional Medical Center Comprehensive Cancer Center, Palm Springs, CA, outlined the considerable demands and complications that have been added to oncology care with the introduction of the Risk Evaluation and Mitigation Strategies (REMS) program for high-risk drugs.
Read More
Oncologists Debate the Place of Pathways and Guidelines in Clinical Practice
By
Daniel Denvir
ACCC Conference
April 2011, Vol 2, No 2
Read More
Implementing the HITECH Rules in Oncology Practices
By
Gena Cook
ACCC Conference
April 2011, Vol 2, No 2
Read More
NCCN 2011 Clinical Guidelines Updates
By
Robert W. Carlson, MD
Clinical Guidelines
,
NCCN Conference
,
Policies & Guidelines
April 2011, Vol 2, No 2
Chairpersons of the various National Comprehensive Cancer Network (NCCN) tumor panels presented clinical practice updates at the recent 16th Annual Conference of the NCCN. Key updates, and relevant discussions, are highlighted.
Read More
Denosumab a New Option for Preventing Skeletal-Related Events in Advanced Cancer
In the Literature
April 2011, Vol 2, No 2
Read More
KRAS Mutation Predicts Treatment Outcomes of Anti-EGFR Therapies
In the Literature
April 2011, Vol 2, No 2
Read More
National Projections: 27% Rise in Cost of Cancer Care in 2020
In the Literature
April 2011, Vol 2, No 2
Read More
Page 318 of 330
315
316
317
318
319
320
321
Top Trending Articles
1.
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumors
2.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
3.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma